In reply.

Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol (2012) 3.96

Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol (2013) 1.08

A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med (2009) 14.40

Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med (2004) 9.62

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11

Fetal pulse oximetry and cesarean delivery. N Engl J Med (2006) 4.45

Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol (2006) 3.87

Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med (2010) 3.81

Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol (2013) 3.46

Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15

The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol (2011) 2.96

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med (2007) 2.73

Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol (2006) 2.69

Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61

Underreporting of pregnancy-related mortality in the United States and Europe. Obstet Gynecol (2005) 2.41

Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol (2012) 2.24

Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19

Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70

First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol (2012) 1.66

Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65

The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54

Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery. Obstet Gynecol (2007) 1.42

Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34

Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. Am J Obstet Gynecol (2011) 1.24

Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. Am J Obstet Gynecol (2009) 1.23

Failed labor induction: toward an objective diagnosis. Obstet Gynecol (2011) 1.18

Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol (2007) 1.13

The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol (2006) 1.09

Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol (2010) 1.08

Pregnancy-related deaths in four regions of Europe and the United States in 1999-2000: characterisation of unreported deaths. Eur J Obstet Gynecol Reprod Biol (2006) 1.07

Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol (2005) 1.06

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol (2009) 1.05

The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol (2005) 1.02

Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol (2008) 1.02

Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol (2007) 1.00

Maternal 25-hydroxyvitamin d and preterm birth in twin gestations. Obstet Gynecol (2013) 0.99

Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol (2012) 0.99

Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstet Gynecol (2010) 0.99

Does information available at admission for delivery improve prediction of vaginal birth after cesarean? Am J Perinatol (2009) 0.97

The change in the rate of vaginal birth after caesarean section. Paediatr Perinat Epidemiol (2010) 0.96

Previous preterm cesarean delivery and risk of subsequent uterine rupture. Obstet Gynecol (2008) 0.96

The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet Gynecol (2012) 0.96

The MFMU Cesarean Registry: impact of fetal size on trial of labor success for patients with previous cesarean for dystocia. Am J Obstet Gynecol (2006) 0.96

Fish consumption, erythrocyte fatty acids, and preterm birth. Obstet Gynecol (2011) 0.95

Complications of anesthesia for cesarean delivery. Obstet Gynecol (2005) 0.95

Labor outcomes with increasing number of prior vaginal births after cesarean delivery. Obstet Gynecol (2008) 0.95

Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol (2006) 0.91

Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol (2013) 0.87

Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus. Am J Obstet Gynecol (2012) 0.86

The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Beneficial Effects of Antenatal Repeated Steroids study: impact of repeated doses of antenatal corticosteroids on placental growth and histologic findings. Am J Obstet Gynecol (2007) 0.83

The Maternal-Fetal Medicine Unit cesarean registry: trial of labor with a twin gestation. Am J Obstet Gynecol (2005) 0.83

Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population. PLoS One (2013) 0.83

Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Am J Obstet Gynecol (2010) 0.83

Timing of delivery and pregnancy outcomes among laboring nulliparous women. Am J Obstet Gynecol (2011) 0.82

Standardized severe maternal morbidity review: rationale and process. Obstet Gynecol (2014) 0.81

Neonatal outcomes in twin pregnancies delivered moderately preterm, late preterm, and term. Am J Perinatol (2010) 0.81

Maternal-Fetal Medicine Units Network cesarean registry: impact of shift change on cesarean complications. Am J Obstet Gynecol (2008) 0.81

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate. J Matern Fetal Neonatal Med (2010) 0.80

Enhanced surveillance of maternal mortality in North Carolina. N C Med J (2002) 0.79

Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroids. Obstet Gynecol (2008) 0.79

The effect of maternal body mass index on neonatal outcome in women receiving a single course of antenatal corticosteroids. Am J Obstet Gynecol (2009) 0.78

Increasing maternal body mass index and characteristics of the second stage of labor. Obstet Gynecol (2011) 0.78

Cesarean delivery for the second twin. Obstet Gynecol (2008) 0.78

Gestational age-specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor. Am J Obstet Gynecol (2013) 0.77

The obstetric and neonatal implications of a low value on the 50-g glucose screening test. Am J Perinatol (2012) 0.77

Population versus customized fetal growth norms and adverse outcomes in an intrapartum cohort. Am J Perinatol (2012) 0.76

Relationship between fetal station and successful vaginal delivery in nulliparous women. Am J Perinatol (2012) 0.75

Advanced lipoprotein measures and recurrent preterm birth. Am J Obstet Gynecol (2013) 0.75

Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. Obstet Gynecol (2016) 0.75

Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2. Am J Obstet Gynecol (2011) 0.75

Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes. Obstet Gynecol (2012) 0.75

Haptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort. J Matern Fetal Neonatal Med (2014) 0.75

Accuracy of sonographic chorionicity classification in twin gestations. J Ultrasound Med (2014) 0.75

In reply: peripartum cardiomyopathy. Obstet Gynecol (2013) 0.75

Supporting breastfeeding mothers in hospital: part 2b. Paediatr Nurs (2007) 0.75

The Maternal-Fetal Medicine Units Cesarean Registry: safety and efficacy of a trial of labor in preterm pregnancy after a prior cesarean delivery. Am J Obstet Gynecol (2006) 0.75

Supporting breastfeeding mothers in hospital: part 1. Paediatr Nurs (2007) 0.75

Standardized severe maternal morbidity review: rationale and process. J Obstet Gynecol Neonatal Nurs (2014) 0.75

Supporting breastfeeding mothers in hospital: part 2a. Paediatr Nurs (2007) 0.75

Trial of labor after one previous cesarean delivery for multifetal gestation. Obstet Gynecol (2007) 0.75